[
  {
    "ts": "2025-01-15T21:13:11+00:00",
    "headline": "Charles River CEO reveals drop in 2025 revenue outlook at JP Morgan",
    "summary": "At the JP Morgan Healthcare Conference 2025, Charles River CEO blamed low client spending, loss of a contract and other reasons for lower 2025 projections.",
    "url": "https://www.pharmaceutical-technology.com/analyst-comment/charles-river-ceo-reveals-drop-in-2025-revenue-outlook-at-jp-morgan/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "c8622371-75eb-3181-87a3-2544e1ac836a",
      "content": {
        "id": "c8622371-75eb-3181-87a3-2544e1ac836a",
        "contentType": "STORY",
        "title": "Charles River CEO reveals drop in 2025 revenue outlook at JP Morgan",
        "description": "",
        "summary": "At the JP Morgan Healthcare Conference 2025, Charles River CEO blamed low client spending, loss of a contract and other reasons for lower 2025 projections.",
        "pubDate": "2025-01-15T21:13:11Z",
        "displayTime": "2025-01-15T21:13:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/676cb10bbb02197e54b6cbb22f468701",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/58FO1t2v6TYl010Y336EDg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/676cb10bbb02197e54b6cbb22f468701.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jMOOD_eQQTpsKwmd0tVa3g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/676cb10bbb02197e54b6cbb22f468701.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/analyst-comment/charles-river-ceo-reveals-drop-in-2025-revenue-outlook-at-jp-morgan/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-ceo-reveals-drop-211311263.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]